about
Indoor salt water baths followed by artificial ultraviolet B light for chronic plaque psoriasisThe role of hormones in the pathogenesis of psoriasis vulgarisPsoriasis and Atopic Dermatitis.Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathwaysAdalimumab: A Review in Chronic Plaque Psoriasis.Gastrointestinal comorbidities in patients with psoriatic arthritis.Epidemiology of mental health comorbidity in psoriasis.Clinic-based Group Multi-professional Education Causes Significant Decline in Psoriasis Severity: A Randomized Open Label Pilot Study.Subclinical atherogenesis in patients with mild psoriasis: A role for IL-6?Changes in circulating cell-free DNA and nucleosomes in patients with exacerbated psoriasis.Autoantigens ADAMTSL5 and LL37 are significantly upregulated in active Psoriasis and localized with keratinocytes, dendritic cells and other leukocytes.Real-world burden of comorbidities in US patients with psoriatic arthritis.Dimethyl- and monomethylfumarate regulate indoleamine 2,3-dioxygenase (IDO) activity in human immune cells.Biosimilar Drugs for Psoriasis: Principles, Present, and Near Future.Sexy again: the renaissance of neutrophils in psoriasis.Transcription Factor Retinoid-Related Orphan Receptor γt: A Promising Target for the Treatment of Psoriasis.Prevalence of smoking, alcohol consumption and metabolic syndrome in patients with psoriasis.Intestinal Microbiota Influences Non-intestinal Related Autoimmune Diseases.Targeting p19 as a treatment option for psoriasis: an evidence-based review of guselkumab
P2860
Q24188256-76D8F291-3E5D-46B6-B4EF-BD911A02FBD7Q26752733-365CFB1E-ABCF-4A28-B7B0-2A462C15E435Q30238648-F93BFE44-7F14-48C5-BAC0-18A377CDA42BQ35803992-2ED2EA47-FBB3-4ED1-B06B-4EAFC6298F22Q38639495-1157D56E-1EE0-4362-A932-967B1699B2B6Q40619895-78C2CCFB-EE50-4F2F-A256-6EEE81B80971Q45983342-140AC0AD-7E0A-415E-AA13-0E7235427A9CQ47144625-BD1D79DC-0124-4FF0-9664-0C917BF55184Q47312304-444C41A9-CD12-4B18-AEBB-F2039947651CQ47658770-55E38FB8-79A4-4F64-87F7-40E1B9351109Q48176521-7934E6C7-D733-47EC-9455-5D7F8050BBE2Q50045761-B25C0C99-5113-4B55-B09C-8A3B1A84A2E7Q51665025-EA0B0444-2EEC-4F59-A0BF-67E2DF808EDAQ52651099-381E6B96-7C2D-4B3D-857D-59F0EE01A5DEQ53096910-0EFD665D-6BF4-431E-8123-0A7E21D4B37DQ55031102-A906CEEC-5BFA-4423-89A2-056EFE5630E6Q55067182-B24EF539-D95D-4582-8B14-6DB201EAD893Q55195884-29C821D0-7B4D-425A-8813-BD2A517BBEC5Q58720009-F8046817-9A5C-46B6-B66C-87B4C9A432D5
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Psoriasis: classical and emerging comorbidities
@ast
Psoriasis: classical and emerging comorbidities
@en
Psoriasis: classical and emerging comorbidities
@nl
type
label
Psoriasis: classical and emerging comorbidities
@ast
Psoriasis: classical and emerging comorbidities
@en
Psoriasis: classical and emerging comorbidities
@nl
prefLabel
Psoriasis: classical and emerging comorbidities
@ast
Psoriasis: classical and emerging comorbidities
@en
Psoriasis: classical and emerging comorbidities
@nl
P2093
P2860
P1476
Psoriasis: classical and emerging comorbidities
@en
P2093
Bruno de Oliveira Rocha
Gleison Vieira Duarte
Maria de Fátima Santos Paim de Oliveira
P2860
P356
10.1590/ABD1806-4841.20153038
P407
P5008
P577
2015-01-01T00:00:00Z